课题基金 / 基金详情

GAMMAR IV OR PLACEBO IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)

GAMMAR IV OR PLACEBO IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)
GAMMAR IV 或安慰剂治疗慢性炎症性脱髓鞘性多发性神经病 (CIDP)
批准号:
6282763
负责人:
PETER DONOFRIO
金额:
$3.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30

项目摘要

项目成果

PETER DONOFRIO的其他基金

相似基金

相关文献

中文摘要
翻译
慢性炎症性脱髓鞘性多神经病变(CIDP)是一种免疫性疾病
英文摘要
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune- mediated motor disorder that accounts for approximately 20% of apparently undiagnosed neuropathies referred to tertiary care centers. Although their contributions are unclear, it is thought that both cellular and humoral immune mechanisms play a part in the etiology of CIDP. Improvement has been noted in CIDP patients previously unresponsive to other therapies with IVIG. This treatment is easier and less risky than customary treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL OF CELEBREX IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS
CLINICAL TRIAL OF COENZYME Q10 IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS
Clinical Trial of Coenzyme Q10 in Patients with Amyotrophic Lateral Sclerosis
Clinical Trial of Celebrex in Subjects with Amyotrophic Lateral Sclerosis
海外基金